Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Regenxbio (RGNX) over the last 11 years, with Q3 2025 value amounting to 0.29.

  • Regenxbio's Asset Utilization Ratio rose 8823.33% to 0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29, marking a year-over-year increase of 8823.33%. This contributed to the annual value of 0.16 for FY2024, which is 2494.92% up from last year.
  • Per Regenxbio's latest filing, its Asset Utilization Ratio stood at 0.29 for Q3 2025, which was up 8823.33% from 0.29 recorded in Q2 2025.
  • Regenxbio's Asset Utilization Ratio's 5-year high stood at 0.52 during Q3 2022, with a 5-year trough of 0.11 in Q3 2021.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.17 (2024), whereas its average is 0.25.
  • Data for Regenxbio's Asset Utilization Ratio shows a peak YoY increase of 35917.62% (in 2022) and a maximum YoY decrease of 7328.09% (in 2022) over the last 5 years.
  • Regenxbio's Asset Utilization Ratio (Quarter) stood at 0.49 in 2021, then plummeted by 73.28% to 0.13 in 2022, then increased by 13.81% to 0.15 in 2023, then grew by 13.21% to 0.17 in 2024, then soared by 72.4% to 0.29 in 2025.
  • Its Asset Utilization Ratio stands at 0.29 for Q3 2025, versus 0.29 for Q2 2025 and 0.33 for Q1 2025.